So we have just published a guideline on the indications for PET-CT in the staging of breast cancer. And it is a guideline that has been directed by the European Association of Nuclear Medicine and also the American Society of Nuclear Medicine and Molecular Imaging. And it has also the endorsement of many European societies, like the European Society of Surgical Oncology, Radiation Oncology, and so on...
So we have just published a guideline on the indications for PET-CT in the staging of breast cancer. And it is a guideline that has been directed by the European Association of Nuclear Medicine and also the American Society of Nuclear Medicine and Molecular Imaging. And it has also the endorsement of many European societies, like the European Society of Surgical Oncology, Radiation Oncology, and so on. And what we are looking is to identify in which population at which stage of the breast cancer disease the PET will give us more information that will help in deciding treatments and also systemic treatments and local regional treatments. So we will go through these guidelines and see pros and cons of using the PET for staging in the different stages of the disease.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
